Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells. - Pieper, M.; Scheffold, C.; Duwe, S.; Rossig, C.; Bisping, G.; Stelljes, M.; Tedder, T. F.; Jurgens, H.; Berdel, W. E.; Kienast, J. (Leukemia (08876924), 2006)